| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.1 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.079 | 0.2 |